Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Metabolism: Phase I Reactions

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Organic Chemical Contaminants in Water System Infrastructure Following Wildfire.

ACS ES&T water·2022

Same author

Photochemical generation and kinetic studies of a putative porphyrin-ruthenium(V)-oxo species.

Dalton transactions (Cambridge, England : 2003)·2014

Same author

SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.

Cancer prevention research (Philadelphia, Pa.)·2014

Same author

Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease.

Investigative ophthalmology & visual science·2013

Same author

Bioluminescent detection of peroxynitrite with a boronic acid-caged luciferin.

Free radical biology & medicine·2013

Same author

Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease.

Investigative ophthalmology & visual science·2012

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces

Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces

Published on: September 26, 2014

Cytochrome p450 compound I.

Martin Newcomb¹, Rui Zhang, R Esala P Chandrasena

¹Department of Chemistry, University of Illinois at Chicago, Chicago, Illinois 60607, USA. men@uic.edu

Journal of the American Chemical Society

|April 6, 2006

Summary

This summary is machine-generated.

Researchers have identified key reactive intermediates, Compound II and Compound I, in Cytochrome P450 enzymes (P450s). This study demonstrates the formation and characterization of these crucial P450 oxidation states.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by ³²P-postlabeling

Published on: March 20, 2018

Related Experiment Videos

Last Updated: Jul 10, 2026

Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces

Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces

Published on: September 26, 2014

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by ³²P-postlabeling

Published on: March 20, 2018

Area of Science:

Biochemistry
Enzymology
Chemical Kinetics

Background:

Cytochrome P450 enzymes (P450s) are vital catalysts for numerous biological oxidations.
The precise nature of the active oxidant in P450 catalysis, specifically Compound I (an iron(IV)-oxo porphyrin radical cation), has been a long-standing question in the field.

Purpose of the Study:

To synthesize and characterize the Compound I intermediate of a P450 enzyme.
To investigate the reaction mechanism and stability of P450 oxidation states.

Main Methods:

Laser flash photolysis was employed to generate and study transient intermediates.
Peroxynitrite was used as an oxidant to produce the Compound II intermediate.
Spectroscopic methods were utilized to monitor the formation and decay kinetics of Compound II and Compound I.

Main Results:

The Compound II derivative of P450 CYP119 was successfully generated and observed to be stable for seconds at ambient temperature.
The Compound I derivative was formed via oxidation of Compound II and its transient decay kinetics were determined, with a lifetime of approximately 200 ms.

Conclusions:

This study provides direct evidence for the formation of Compound I in a P450 enzyme.
The findings offer significant insights into the catalytic mechanism of P450 enzymes and the nature of their reactive intermediates.